CompletedPHASE1, PHASE2NCT00962182

Study of Enzyme Supplements to Treat Celiac Disease

Studying Dermatitis herpetiformis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Heim Pal Children's Hospital
Principal Investigator: Ilma Korponay-Szabo, M.D., Ph.D.
Heim Pal Children's Hospital
Intervention: STAN1(drug)
Enrollment: 38 enrolled
Eligibility: 12-65 years · All sexes
Timeline: 2008 – 2017

Study locations (2)

Heim Pal Children's Hospital, Budapest, Hungary
University of Debrecen, Debrecen, Hungary

Collaborators

Stanford University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00962182 on ClinicalTrials.gov

Other trials for Dermatitis herpetiformis

Additional recruiting or active studies for the same condition.

See all trials for Dermatitis herpetiformis →

← Back to all trials